Anne Jokilammi

431 total citations
23 papers, 321 citations indexed

About

Anne Jokilammi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Anne Jokilammi has authored 23 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Immunology. Recurrent topics in Anne Jokilammi's work include Glycosylation and Glycoproteins Research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Anne Jokilammi is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Anne Jokilammi collaborates with scholars based in Finland, Germany and United States. Anne Jokilammi's co-authors include Jukka Finne, Klaus Elenius, Harri Hirvonen, Ilkka Paatero, Miikka Korja, Pauli Ollikka, David Schwarzer, Mark E. Bowen, Andrea Zelmer and Peter W. Taylor and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Scientific Reports.

In The Last Decade

Anne Jokilammi

23 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Jokilammi Finland 10 211 60 55 45 38 23 321
Gerald Moncayo Switzerland 10 321 1.5× 76 1.3× 131 2.4× 37 0.8× 21 0.6× 12 532
Alexander C. James Australia 10 302 1.4× 101 1.7× 62 1.1× 21 0.5× 19 0.5× 15 531
Hidetaka Tanno United States 10 205 1.0× 79 1.3× 156 2.8× 35 0.8× 92 2.4× 13 386
Seungmin Shin South Korea 10 261 1.2× 109 1.8× 70 1.3× 33 0.7× 122 3.2× 24 425
Keiko Hiemori Japan 11 392 1.9× 45 0.8× 134 2.4× 49 1.1× 48 1.3× 24 464
Annat Raiter Israel 15 238 1.1× 79 1.3× 137 2.5× 179 4.0× 75 2.0× 33 499
Bo R. Hansen Denmark 8 518 2.5× 52 0.9× 34 0.6× 51 1.1× 8 0.2× 11 611
Naomi J. Clout United Kingdom 8 306 1.5× 52 0.9× 212 3.9× 80 1.8× 57 1.5× 8 601
Hong Seo Choi South Korea 12 272 1.3× 86 1.4× 60 1.1× 48 1.1× 21 0.6× 24 422

Countries citing papers authored by Anne Jokilammi

Since Specialization
Citations

This map shows the geographic impact of Anne Jokilammi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Jokilammi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Jokilammi more than expected).

Fields of papers citing papers by Anne Jokilammi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Jokilammi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Jokilammi. The network helps show where Anne Jokilammi may publish in the future.

Co-authorship network of co-authors of Anne Jokilammi

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Jokilammi. A scholar is included among the top collaborators of Anne Jokilammi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Jokilammi. Anne Jokilammi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jokilammi, Anne, Pia Rantakari, Pauliina Kronqvist, et al.. (2024). Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo. ChemBioChem. 25(18). e202400264–e202400264. 1 indexed citations
2.
Jokilammi, Anne, et al.. (2024). Empagliflozin attenuates hypoxia-induced heart failure of zebrafish embryos via influencing MMP13 expression. Biomedicine & Pharmacotherapy. 180. 117453–117453. 2 indexed citations
3.
Jokilammi, Anne, Ilkka Paatero, Karthik Amudhala Hemanthakumar, et al.. (2023). STAT5b is a key effector of NRG ‐1/ ERBB4 ‐mediated myocardial growth. EMBO Reports. 24(5). e56689–e56689. 5 indexed citations
4.
Lehti, Timo A., Maria I. Pajunen, Anne Jokilammi, et al.. (2021). Design of a Cytotoxic Neuroblastoma-Targeting Agent Using an Enzyme Acting on Polysialic Acid Fused to a Toxin. Molecular Cancer Therapeutics. 20(10). 1996–2007. 1 indexed citations
5.
Jokilammi, Anne, et al.. (2021). Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia. Scientific Reports. 11(1). 16661–16661. 4 indexed citations
6.
Jokilammi, Anne, et al.. (2018). Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target. BMC Cardiovascular Disorders. 18(1). 196–196. 13 indexed citations
7.
Boström, Pia, Annele Sainio, Natalja Eigėlienė, et al.. (2017). Human Metaplastic Breast Carcinoma and Decorin. Cancer Microenvironment. 10(1-3). 39–48. 8 indexed citations
8.
Stamatos, Nicholas M., Anne Jokilammi, Jukka Finne, et al.. (2014). Changes in polysialic acid expression on myeloid cells during differentiation and recruitment to sites of inflammation: Role in phagocytosis. Glycobiology. 24(9). 864–879. 39 indexed citations
9.
Nordfors, Kristiina, Jukka Finne, Anne Jokilammi, et al.. (2014). Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas. BMC Cancer. 14(1). 623–623. 7 indexed citations
10.
Paatero, Ilkka, Anne Jokilammi, Pekka T. Heikkinen, et al.. (2012). Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α Signaling. Journal of Biological Chemistry. 287(13). 9659–9671. 35 indexed citations
11.
Schwarzer, David, et al.. (2012). Endosialidases: Versatile Tools for the Study of Polysialic Acid. Topics in current chemistry. 367. 29–73. 26 indexed citations
12.
Stark, Christoffer, et al.. (2010). Hemoglobin expression in rat experimental granulation tissue. Journal of Molecular Cell Biology. 3(3). 190–196. 11 indexed citations
13.
Jokilammi, Anne, et al.. (2009). Hydroxyapatite coating of cellulose sponges attracts bone-marrow-derived stem cells in rat subcutaneous tissue. Journal of The Royal Society Interface. 6(39). 873–880. 15 indexed citations
14.
Korja, Miikka, Anne Jokilammi, Toivo T. Salmi, et al.. (2009). Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma. BMC Cancer. 9(1). 57–57. 28 indexed citations
15.
Zelmer, Andrea, Mark E. Bowen, Anne Jokilammi, et al.. (2008). Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1. Microbiology. 154(8). 2522–2532. 33 indexed citations
16.
17.
Jokilammi, Anne, Pauli Ollikka, Miikka Korja, et al.. (2004). Construction of antibody mimics from a noncatalytic enzyme–detection of polysialic acid. Journal of Immunological Methods. 295(1-2). 149–160. 31 indexed citations
18.
Haapamäki, Markku M., Juha Grönroos, Anne Jokilammi, et al.. (1997). Serum Phospholipases A 2 in Patients Undergoing Panproctocolectomy Because of Severe Ulcerative Colitis. Clinical Chemistry and Laboratory Medicine (CCLM). 35(10). 749–754. 2 indexed citations
19.
Jokilammi, Anne, et al.. (1996). Time‐resolved fluoroimmunoassay for bactericidal/permeability‐increasing protein. Mediators of Inflammation. 5(1). 47–50. 4 indexed citations
20.
Arpalahti, Jorma, Anne Jokilammi, Harri Hakala, & Harri Lönnberg. (1991). Depurination of (dien)Pt(II) complexes of purine deoxyribonucleosides. Comparison with the effects of (dien)Pd(II) ion complexing. Journal of Physical Organic Chemistry. 4(5). 301–309. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald Moncayo Breakdown of academic impact, for papers by Alexander C. James Breakdown of academic impact, for papers by Hidetaka Tanno Breakdown of academic impact, for papers by Seungmin Shin Breakdown of academic impact, for papers by Keiko Hiemori Breakdown of academic impact, for papers by Annat Raiter Breakdown of academic impact, for papers by Bo R. Hansen Breakdown of academic impact, for papers by Naomi J. Clout Breakdown of academic impact, for papers by Hong Seo Choi
Rankless by CCL
2026